• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106015
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446); Skin Infection (4544); Lactate Dehydrogenase Increased (4567)
Event Date 06/21/2022
Event Type  Death  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient had rising lactate dehydrogenase (ldh) levels.A review of the log files found low voltage hazard events on battery power on (b)(6) 2022 at 19:47 - 19:59 due to the batteries being near depleted and both power leads being disconnected causing no external power alarms until fully charged batteries were connected.On (b)(6) 2022, 08:52 - 10:46 there were low flow events noted, the flow recovered into the 3-4 liters per minute (lpm) range and there were no further events noted in the remainder of the log.The rising ldh was believed to be caused by suspected pump thrombosis.The patient had recent infections which were believed to potentially have contributed to the thrombosis.There were no recent changes to pump parameters or diagnostic testing done.The patient was transitioned to comfort care and ultimately expired on (b)(6) 2022 due to end stage systolic heart failure.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: the report of suspected thrombus could not be confirmed as no product was returned for evaluation.A direct correlation between the heartmate ii lvas, serial number (b)(6), and the reported elevated events could not be conclusively established through this evaluation.Evaluation of the submitted log file revealed a persistent low flow hazard alarm that occurred on 21jun2022 at 08:52:23 to 10:46:07 when the flow fell below the low flow threshold of 2.5 lpm to a consistent 2.4 lpm.By 11:56:17 on 21jun2022, the flow returned to normal parameters for the remainder of the log file.A specific cause for the low flow alarms could not be conclusively determined through this evaluation.No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate ii lvas instructions for use (ifu) and the heartmate ii patient handbook are currently available.Section 1 of the ifu, ¿introduction¿, lists hemolysis, device thrombosis, and death as an adverse event that may be associated with the use of the heartmate ii left ventricular assist system.Section 1 and section 6 of the ifu, ¿patient care and management¿, outline indications of pump thrombosis and how to respond to such events.Section 6, under ¿anticoagulation¿, provides information regarding the recommended anticoagulation therapy and inr range, as well as suggested anticoagulation modifications.Heartmate ii lvas ifu section 1 "introduction" provides an explanation of all pump parameters, including pump flow.Section 4 ¿system monitor¿ provides more information regarding all pump parameters and also describes situations which may result in a low flow hazard alarm, including changes in patient conditions such as hypertension.Section 4 also provides information on reviewing the event history on the system monitor.Section 6 "patient care and management" (under "pump performance monitoring") explains that pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling, explains that pump flow is estimated from pump power, and addresses assessing pump flow.Section 6 (under "postoperative patient care") also cautions: "physiological factors that affect the filling of the pump, such as hypovolemia or postural hypotension, results in reduced pump flows as long as the condition persists.Pump flows are not restored to normal unless such conditions are treated." section 7 ¿alarms and troubleshooting¿ describes all alarm conditions, including the low flow hazard, as well as the appropriate actions associated with them.Heartmate ii lvas patient handbook section 5 "alarms and troubleshooting" outlines all system controller alarms as well as how to respond to each alarm condition.This document instructs the user that in the event of a low flow hazard alarm, call your hospital contact immediately for diagnosis and instructions.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key15069718
MDR Text Key296284669
Report Number2916596-2022-12192
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/27/2021
Device Model Number106015
Device Catalogue Number106015
Device Lot Number7370688
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/30/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient SexMale
Patient Weight101 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-